IMTXW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
Dagens volum	1 302
Gjennomsnittsvolum	0
Markedsverdi	1.26B
EPS	$-0.0311 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0280 (0.93%)

AADI -6.18%

ABCL 2.20%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 5.14%

ABSI 4.08%

ABUS -0.82%

ABVX -1.88%

ACAD 0.00%

ACER -17.95%

ACET -8.53%

ACGN 1.29%

ACHL -2.48%

ACHV 3.89%

ACIU -1.00%

ACLX 0.09%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.73%

ADGI 0.87%

ADIL -1.70%

ADMA -1.77%

ADPT 0.74%

ADTX -2.78%

ADVM 1.45%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.29%

AGIO -1.90%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.18%

AKRO -2.45%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.82%

ALLK -11.49%

ALLO -4.17%

ALLR -2.50%

ALNA 3.16%

ALNY 2.16%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -14.02%

ALVR -0.69%

ALXN 0.00%

ALXO -13.76%

ALZN 4.02%

AMRN -2.50%

AMTI -3.13%

ANAB 1.64%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.51%

ANPC -3.15%

APGE 0.75%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 1.06%

APLT -0.68%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 2.04%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.52%

ARDS -12.13%

ARDX 0.85%

ARGX -0.49%

ARNA 0.00%

ARPO -0.90%

ARQT -2.50%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.73%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -2.03%

ATAI -3.33%

ATHA 6.86%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.83%

ATRA -3.60%

ATXI 2.70%

ATXS -0.22%

AUPH -0.99%

AURA 4.55%

AUTL -3.02%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.34%

AVTX -3.74%

AVXL -4.82%

AXLA 0.00%

AXSM -1.29%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.16%

BCAB -3.01%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.93%

BCTX 8.16%

BCTXW 13.02%

BCYC 0.95%

BDRX -4.09%

BDTX 0.23%

BEAM 2.52%

BFRA -2.91%

BGNE -2.02%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.03%

BLU 0.03%

BLUE -2.28%

BMEA -13.82%

BMRN 0.53%

BNOX 6.15%

BNTC -1.69%

BNTX -1.74%

BOLD -7.90%

BOLT -0.05%

BPMC -1.41%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.13%

BTAI 12.71%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 1.73%

CADL 0.62%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.86%

CCXI 0.00%

CDAK 0.00%

CDIO -5.08%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.79%

CDXS 9.31%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.52%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.30%

CGEN -3.31%

CGON -1.53%

CGTX -4.35%

CHMA -6.00%

CHRS 4.13%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.58%

CLGN -0.20%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.54%

CNCE 0.00%

CNSP -36.15%

CNST 0.00%

CNTA 0.00%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.53%

COYA -0.65%

CPRX -1.72%

CRBP -0.43%

CRBU -6.82%

CRDF 1.77%

CRGX 0.10%

CRIS -1.59%

CRNX -5.96%

CRSP -0.09%

CRTX 2.63%

CRVO -2.33%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -2.89%

CTNM 1.98%

CTXR -1.31%

CUE -1.73%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.44%

CYTO 0.00%

DARE 3.54%

DAWN -0.82%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.08%

DNLI -1.74%

DNTH -4.87%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.72%

EDSA 4.09%

EFTR 5.36%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -0.83%

ELOX 10.77%

ELTX -5.15%

ELVN -1.82%

ELYM 4.60%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.08%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.24%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.94%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.21%

EXAI -0.19%

EXEL 0.47%

EYEG -0.69%

EYEN 0.23%

EYPT 1.69%

FATE -11.42%

FBIO 0.86%

FBIOP 0.87%

FBLG -7.30%

FBRX -0.02%

FDMT -4.99%

FENC -2.26%

FGEN -9.87%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.37%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.16%

FULC 1.84%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.54%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.51%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -2.46%

GNTA 3.94%

GOSS -10.88%

GOVX -2.73%

GOVXW 10.89%

GPCR -6.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.01%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.64%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -1.34%

HOOK 0.89%

HOTH -1.10%

HOWL 2.10%

HRMY 5.05%

HRTX 8.84%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.26%

IBRX -5.50%

ICCC -4.42%

ICPT 0.21%

ICU 15.41%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.16%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.00%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -6.93%

IMNM 4.25%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.00%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -1.68%

INBX -2.55%

INCY -2.36%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 3.22%

INMB 4.90%

INO 2.08%

INSM -0.98%

INTS -1.96%

INVA 0.29%

INZY 2.29%

IOBT -10.94%

IONS 1.50%

IOVA -2.40%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.68%

ISEE 0.38%

ITOS 1.57%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.56%

JAZZ -0.82%

JNCE 0.00%

JSPR -1.91%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.99%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.51%

KPRX -3.60%

KPTI -9.43%

KRBP -10.00%

KRON 1.68%

KROS -0.41%

KRRO -2.30%

KRTX 0.03%

KRYS 0.27%

KTRA 12.27%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.79%

KYTX -3.60%

KZIA 4.41%

KZR -0.12%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.97%

LENZ -1.92%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -9.31%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.41%

LRMR 0.50%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.77%

LXRX -2.35%

LYEL -35.54%

LYRA 1.94%

MACK 0.10%

MBIO -11.56%

MBRX -1.43%

MCRB 2.60%

MDGL -2.34%

MDNA -13.16%

MDWD 3.56%

MDXG -2.06%

MEIP 0.00%

MESO -1.63%

MGNX -4.55%

MGTA -7.74%

MGTX -0.95%

MGX 2.41%

MIRM 0.45%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.10%

MLYS -6.00%

MNKD -0.76%

MNMD 4.38%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.58%

MREO -2.00%

MRKR -0.43%

MRNA -9.42%

MRNS -5.51%

MRSN -2.85%

MRTX -0.17%

MRUS -0.58%

MRVI -0.44%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.33%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 9.91%

NKGNW -18.03%

NKTR 4.21%

NKTX -4.00%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.09%

NMTR -42.97%

NOVN -24.84%

NRBO 16.39%

NRIX -0.39%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.17%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.25%

NTRBW -31.07%

NUVL -0.98%

NVAX -7.61%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.17%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.90%

OCS -1.00%

OCUL 1.14%

OCUP 1.32%

ODT -4.27%

OKYO 2.15%

OLMA -4.77%

OMER -2.31%

OMGA 0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.19%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.66%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -2.18%

PBYI 2.70%

PCSA -1.93%

PCVX 0.05%

PDSB -6.65%

PEPG 1.19%

PGEN -5.99%

PHAR 2.19%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.02%

PLUR 7.39%

PMN -5.55%

PMVP -2.08%

PNT 0.16%

PPBT -6.43%

PRAX 7.11%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.72%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.33%

PTCT -0.63%

PTE -0.82%

PTGX -1.13%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 3.91%

QLGN -7.22%

QNCX 5.70%

QNRX -0.15%

QSI -35.63%

QSIAW -3.13%

QTTB 1.83%

QURE -0.90%

RAIN -1.63%

RANI 4.81%

RAPT -1.62%

RARE 1.91%

RCKT -9.64%

REGN -0.24%

RENB -2.78%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.96%

RGNX -6.58%

RIGL -6.25%

RLAY -4.60%

RLMD 0.00%

RLYB -4.03%

RNA 1.95%

RNAC -4.70%

RNAZ 0.00%

RNXT 1.79%

ROIV -1.71%

ROIVW 4.56%

RPHM -1.39%

RPRX -0.59%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.54%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.70%

RYTM -5.87%

RYZB 0.02%

RZLT 3.50%

SABS -1.37%

SABSW -11.81%

SAGE 0.64%

SANA -2.58%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.51%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.30%

SGTX -2.56%

SIOX 22.63%

SLDB -3.97%

SLGL 5.23%

SLN -6.37%

SLNO 0.77%

SLRX 1.21%

SLS -2.56%

SMMT -3.25%

SNDX 3.28%

SNGX -0.38%

SNPX -2.55%

SONN -2.13%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.17%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.50%

STSA 0.00%

STTK 6.91%

SURF -0.93%

SVRA -0.32%

SWTX 0.25%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -7.38%

TARS -2.01%

TBPH 0.77%

TCBP 6.94%

TCDA 0.00%

TCON -0.34%

TCRR 0.00%

TCRT -1.75%

TCRX 4.85%

TECH -0.85%

TENX -0.32%

TERN -8.42%

TFFP -7.61%

TGTX -6.98%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.40%

TNXP -6.80%

TNYA -3.68%

TPST 6.21%

TRDA -4.67%

TRVI 3.07%

TRVN 3.11%

TSHA -19.07%

TSVT -3.99%

TTNP -6.05%

TVTX 3.14%

TYRA -6.95%

UBX -2.55%

UNCY -4.44%

URGN 2.73%

UTHR -0.10%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 0.94%

VCNX 9.03%

VCYT -0.84%

VERA -5.51%

VERU 3.02%

VERV -2.29%

VIGL -1.88%

VINC 2.93%

VIR -0.87%

VIRI -5.72%

VIRX 3.98%

VKTX -1.72%

VLON -13.04%

VNDA -3.94%

VOR -6.05%

VRCA 0.36%

VRDN -3.61%

VRNA -1.60%

VRPX 1.02%

VRTX 0.09%

VSTM 3.91%

VTGN -1.51%

VTVT 0.39%

VTYX -2.55%

VXRT -1.92%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.50%

XBIO 1.03%

XBIT 7.50%

XCUR 3.77%

XENE -1.93%

XERS 5.00%

XFOR 5.21%

XLO 4.42%

XLRN 0.00%

XNCR 0.62%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.07%

ZSAN 0.00%

Korrelasjon (AI algo v.1.1b): Undervalued: 0.07% $3.00 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

immatics biotechnologies Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

immatics biotechnologies Økonomi

Annual	2023
Omsetning:	$54.00M
Bruttogevinst:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2023
Omsetning:	$54.00M
Bruttogevinst:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2022
Omsetning:	$172.83M
Bruttogevinst:	$66.05M (38.22 %)
EPS:	$0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.